Resources
Useful downloads
Find what you need, when you need it—view or download helpful information and tools here.
ILD PATIENT RESOURCES FOR PH-ILD:
ILD Patient Brochure for PH-ILD
Raising questions with your doctor about your lung health may help you do more day to day.
Symptom Tracker
Could the changes in your ILD symptoms really be PH?
Routine Tests
Helpful clues to PH can be uncovered in routine ILD tests.
Myth Buster 1
Checking for PH-ILD: Separating fact from fiction.
Myth Buster 2
Echocardiogram: Separating fact from fiction.
TYVASO RESOURCES FOR PH-ILD:
TYVASO Patient Brochure
A brochure for patients with PH-ILD, who want to learn how TYVASO may help.
TYVASO DPI:
Titration Guide
Quick Tips Guide
Instructions for Use Manual
Prescribing Information
Getting Started on TYVASO DPI
TYVASO DPI is delivered through a portable inhaler that features a simple-to-use design.
TYVASO Nebulizer:
TYVASO
Treatment Tracker
Quick Tips Guide
Instructions for
Use Manual
Prescribing Information
Getting Started on TYVASO
TYVASO is delivered through a portable nebulizer.
Review real stories from patients taking TYVASO
Listen to Sally’s story about her experience starting TYVASO DPI.
Get an update on Catherine’s journey switching to TYVASO DPI.
Hear about Catherine’s journey getting started on the TYVASO nebulizer.
Hear from Tina about her experience with titration using the TYVASO nebulizer.
DPI=dry powder inhaler.
IMPORTANT SAFETY INFORMATION
Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:
- Have low blood pressure
- Have or have had bleeding problems
IMPORTANT SAFETY INFORMATION
Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:
- Have low blood pressure
- Have or have had bleeding problems
- Have asthma or chronic obstructive pulmonary disease (COPD)
- Are pregnant or plan to become pregnant. It is not known if either product will harm your unborn baby.
- Are breastfeeding or plan to breastfeed. It is not known if either product passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Either product and other medicines may affect each other.
Especially tell your healthcare provider if you take:
- Medicines used to treat high blood pressure or heart disease
- Medicines that decrease blood clotting (anticoagulants)
- Water pills (diuretics)
- Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)
What are the possible side effects of TYVASO or TYVASO DPI?
Both products can cause serious side effects, including:
- Low blood pressure (symptomatic hypotension). If you have low blood pressure, either product may lower your blood pressure more.
- Bleeding problems. Either product may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).
The most common side effects of both products are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, diarrhea, and shortness of breath. Like other inhaled prostaglandins, you may have trouble breathing after taking TYVASO or TYVASO DPI because it may cause the muscles around your airway to tighten (bronchospasm). These are not all the possible side effects. Call your doctor for medical advice about side effects or if you have trouble breathing.
You may report side effects to the FDA at
You are now leaving the Tyvaso.com website
This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.
or call 1-800-FDA-1088.
What are TYVASO and TYVASO DPI?
TYVASO (treprostinil) Inhalation Solution and TYVASO DPI (treprostinil) Inhalation Powder are prescription medicines used in adults to treat:
- Pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO or TYVASO DPI can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO or TYVASO DPI. It is not known if TYVASO or TYVASO DPI is safe and effective in children under 18 years of age.
- Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability to exercise.
The risk information provided here is not comprehensive. To learn more about TYVASO or TYVASO DPI, talk with your healthcare provider. Please see Full Prescribing Information for TYVASO or TYVASO DPI, Instructions for Use manuals for TD-100 and TD-300 TYVASO® Inhalation System and TYVASO DPI® Inhalation Powder, and additional information at www.TYVASO.com or call 1-844-UNITHER (1-844-864-8437).
TYVISIconSEP2024
